Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
JinFang Pharmaceuticals-B(02595) Included in the Hong Kong Stock Connect Securities List
Zhitong Finance APP News, Jingfang Medicine-B (02595) announced that, according to notices from the Shanghai Stock Exchange and the Shenzhen Stock Exchange, the company will be included in the list of eligible securities for the Stock Connect (Shanghai-Hong Kong and Shenzhen-Hong Kong) starting March 9, 2026. After being included in the Stock Connect, qualified investors from mainland China will be able to directly invest in the company’s shares through the Shanghai and Shenzhen Stock Exchanges.
Starting March 9, 2026, the company will also be included in multiple Hang Seng Index series components, such as the Hang Seng Composite Index, Hang Seng H-Share Index, and Hang Seng Innovation Pharmaceutical Index, as part of the Hang Seng Index Series.